T1	outcome 1239 1250	no response
T2	outcome 1266 1277	progression
T3	outcome 1127 1130	pCR
T4	outcome 800 812	achieved pCR
T5	total-participants 315 341	Three hundred thirty-eight
T6	eligibility 117 161	patients with stage II and III breast cancer
T8	intervention-participants 439 442	101
T9	intervention-participants 487 489	91
T10	intervention-participants 522 525	103
T11	intervention-participants 563 565	43
T12	intervention 88 113	preoperative chemotherapy
T14	age 749 772	44 (range, 21-76) years
T15	eligibility 274 313	stage II and III breast cancer patients
